Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptation and Evaluation of the Mindfulness-Based Relapse Prevention Program for Cessation and/or Reduction of Benzodiazepine Chronic Use to Induce Sleep Among Women

NCT02127411 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT02127411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptation and Evaluation of the Mindfulness-Based Relapse Prevention Program for Cessation and/or Reduction of Benzodiazepine Chronic Use to Induce Sleep Among Women
Lead sponsor
Federal University of São Paulo
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2016
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepine dependence